Lovastatin has direct renal hemodynamic effects in a rodent model

Journal of Urology

Volumn 156, Issue 1, 1996, Pages 249-252

  Stowe, Nicholas T ^a   Inman, Sharon R ^a   Tapolyai, Mehály ^a   Brouhard, Ben H ^a   Hodge, Ernest E ^a   Novick, Andrew C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

glomerular filtration rate; kidney; lovastatin; microcirculation; renal circulation

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; THIOBUTABARBITAL;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HYDRONEPHROSIS; HYPERCHOLESTEROLEMIA; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; KIDNEY FUNCTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0030010996     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66010-5     Document Type: Article

References (25)

1. Diamond, J. R. and Karnovsky, M. J.: A putative role of hypercholesterolemia in progressive glomerular injury. Annu. Rev. Med., 43: 83, 1992.
2. Harris, K. P. G., Purkerson, M. L., Yates, J. and Klahr, S.: Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome. Am. J. Kidney. Dis., 15: 16, 1990.
3. O'Donnell, M. P., Kasiske, B. L., Katz, S. A., Schmitz, P. G. and Keane, W. F.: Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats. Hypertension, 20: 651, 1992.
4. O'Donnell, M. P., Kasiske, B. L., Kim, Y., Schmitz, P. G. and Keane, W. F.: Lovastatin retards the progression of established glomerular disease in obese Zucker rats. Am. J. Kidney. Dis., 22: 83, 1993.
5. Kasiske, B. L., O'Donnell, M. P., Garvis, W. J. and Keane, W. F.: Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ. Res., 62: 367, 1988.
6. Lee, S. K., Jin, S. Y., Han, D. C., Hwang, S. D. and Lee, H. B.: Effects of delayed treatment with enalapril and/or lovastatin on the progression of glomerulosclerosis in 5/6 nephrectomized rats. Nephrol. Dial. Transpl., 8: 1338, 1993.
7. Brouhard, B. H., Takamori, H., Satoh, S., Inman, S., Cressman, M., Irwin, K., Berkley, V. and Stowe, N.: The combination of lovastatin and enalapril in a model of progressive renal disease. Pediatr. Nephrol., 8: 436, 1994.
8. Smith, H.: Principles of Renal Physiology. New York: Oxford University Press, p. 196, 1965.
9. Steinhausen, M., Blum, M., Fleming, J. T., Holtz, F. G., Parekh, N., Wiegman, D. L. and Dussel, R.: Visualization of renal autoregulation in the split hydronephrotic kidney in rats. Kidney Int., 35: 1151, 1989.
10. Inman, S. R., Stowe, N. T., Nally, J. V., Brouhard, B. H. and Vidt, D. G.: Dietary protein does not alter intrinsic reactivity of renal microcirculation to angiotensin II in rodents. Am. J. Physiol., 268: F302, 1995.
11. Sokal, R. R. and Rohlf, F. J.: Biometry. 2nd Ed. New York: Freeman, 1981.
12. Stowe, N. T., Inman, S. R., Brouhard, B. H., Cressman, M. D., Nally, J. V., Vidt, D. G., Sato, S. and Satodate, R.: Combined lovastatin and enalapril prevent deterioration of renal function in diabetes. J. Am. Soc. Nephrol., 4: 804, 1993.
13. O'Donnell, M. P., Kasiske, B. L., Kim, Y., Alturu, D. and Keane, W. F.: Lovastatin inhibits proliferation of rat mesangial cells. J. Clin. Invest., 91: 83, 1993.
14. Aviram, M., Danker, G., Cogan, U., Hochgraf, E. and Brook, G.: Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies. Metabolism, 42: 229, 1992.
15. Navar, L. G., Gilmore, J. P., Joyner, W. L., Steinhausen, M., Edwards, R. M., Casellas, D., Carmines, P. K., Zimmerhackl, L. B. and Yokota, S. D.: Direct assessment of renal microcirculatory dynamics. Fed. Proc., 45: 2851, 1986.
16. Fretschner, M. K., Endlich, E., Gulbins, E., Lang, A. E., Schlottman, K. and Steinhausen, M.: Effects of endothelin on the renal microcirculation of the split hydronephrotic kidney. Renal Physiol. Biochem., 14: 112, 1991.
17. Shenasky, J. H., II, Gillenwater, J. Y., Graham, S. D., Jr. and Wooster, L. D.: Effects of vasoactive drugs on renal vascular resistance in obstructive disease. J. Urol., 106: 355, 1971.
18. Vaughan, E. D., Jr., Sweet, R. C. and Gillenwater, J. Y.: Peripheral renin and blood pressure changes following complete unilateral ureteral occlusion. J. Urol., 104: 89, 1970.
19. Allen, J. T., Vaughan, E. D., Jr. and Gillenwater, J. Y.: The effect of indomethacin on renal blood flow and ureteral pressure in unilateral ureteral obstruction in awake dogs. Invest. Urol., 15: 324, 1978.
20. Berka, J. L., Alcorn, D., Bertram, J. F., Ryan, G. B. and Skinner, S. L.: Effects of converting enzyme inhibition on glomerular number, juxtaglomerular cell activity and renin content in experimental unilateral hydronephrosis. J. Hypertens., 12: 735, 1994.
21. Inman, S. R., Porter, J. P. and Fleming, J. T.: Reduced renal microvascular reactivity to angiotensin II in early diabetes. Microcirculation, 1: 137, 1994.
22. Treasure, C. B., Klein, J. L., Weintraub, W. S., Talley, J. D., Stillabower, M. E., Kosinski, A. S., Zhang, J., Boccuzzi, S. J., Cedarholm, J. C. and Alexander, R. W.: Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N. Engl. J. Med., 332: 481, 1995.
23. Anderson, T. J., Meredith, I. T., Yeung, A. C., Frei, B., Selwyn, A. P. and Ganz, P.: The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N. Engl. J. Med., 332: 488, 1995.
24. Osborne, J. A., Lento, P. H., Siegfried, M. R., Stahl, G. L., Fusman, B. and Lefer, A. M.: Cardiovascular effects of acute hypercholesterolemia in rabbits. J. Clin. Invest., 83: 465, 1989.
25. Iaina, A., Benyamin, G., Levtov, O., Getter, R., Serban, I., Wollman, Y., Rubinstein, A., Cabili, S., Peer, G. and Blum, M.: Effect of chronic cholesterol loading in the development of acute ischemic renal failure in rats. Ren. Fail., 16: 117, 1994.